Business

Hologic stock regains some ground

Hologic’s imaging and surgical products focus on women’s health. Above, ABC’s Amy Robach, a cancer survivor.
Hologic’s imaging and surgical products focus on women’s health. Above, ABC’s Amy Robach, a cancer survivor.ABC via Associated Press

This is a summary. To read the whole story subscribe to BostonGlobe.com

Hologic Inc. regained some ground after two down days following its release of quarterly results that included a net loss of $5.4 million, or 2 cents per diluted share. Revenue was $612 million, better than expected but still down from a year before. ‘‘We clearly have work to do to return to sustainable top and bottom line growth,’’ said Stephen MacMillan, named CEO in November after Carl Icahn disclosed a 13 percent stake in the Bedford company.

Full story for BostonGlobe.com subscribers.

Get the full story with unlimited access to BostonGlobe.com.

Just 99 cents for four weeks.

Share